Skip to content
10-Q

Quarterly Report

Enliven Therapeutics, Inc. ELVN

0001193125-25-277619

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 59.35M sh
Shares Diluted Q3 2025 · Sep 30, 2025 62.09M sh
Shares Diluted Q3 2025 · Sep 30, 2025 54.79M sh
Shares Diluted Q3 2025 · Sep 30, 2024 48.27M sh
Shares Diluted Q3 2025 · Sep 30, 2024 46.14M sh
Capex Q3 2025 · Sep 30, 2025 $158K
Capex Q3 2025 · Sep 30, 2024 $44K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$54.46M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$55.99M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $101.73M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $124.12M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $100.62M
Stockholders Equity Q3 2025 · Sep 30, 2025 $476.12M
Stockholders Equity Q3 2025 · Jun 30, 2025 $488.47M
Stockholders Equity Q3 2025 · Mar 31, 2025 $288.3M
Stockholders Equity Q3 2025 · Dec 31, 2024 $309.85M
Stockholders Equity Q3 2025 · Sep 30, 2024 $288.4M
Stockholders Equity Q3 2025 · Jun 30, 2024 $304.93M
Stockholders Equity Q3 2025 · Mar 31, 2024 $317.71M
Stockholders Equity Q3 2025 · Dec 31, 2023 $245.91M
Current Liabilities Q3 2025 · Sep 30, 2025 $14.65M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.92M
Total Liabilities Q3 2025 · Sep 30, 2025 $14.75M
Total Liabilities Q3 2025 · Dec 31, 2024 $15.92M
Current Assets Q3 2025 · Sep 30, 2025 $482.68M
Current Assets Q3 2025 · Dec 31, 2024 $318.13M
Total Assets Q3 2025 · Sep 30, 2025 $490.88M
Total Assets Q3 2025 · Dec 31, 2024 $325.76M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.32
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.35
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.48
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.43
Eps Basic Q3 2025 · Sep 30, 2025 −$0.32
Eps Basic Q3 2025 · Sep 30, 2025 −$1.35
Eps Basic Q3 2025 · Sep 30, 2024 −$0.48
Eps Basic Q3 2025 · Sep 30, 2024 −$1.43
Sga Expense Q3 2025 · Sep 30, 2025 $6.87M
Sga Expense Q3 2025 · Sep 30, 2025 $20.76M
Sga Expense Q3 2025 · Sep 30, 2024 $5.81M
Sga Expense Q3 2025 · Sep 30, 2024 $17.6M
Rd Expense Q3 2025 · Sep 30, 2025 $18.23M
Rd Expense Q3 2025 · Sep 30, 2025 $64.61M
Rd Expense Q3 2025 · Sep 30, 2024 $21.26M
Rd Expense Q3 2025 · Sep 30, 2024 $60.05M
Net Income Q3 2025 · Sep 30, 2025 −$20.15M
Net Income Q3 2025 · Sep 30, 2025 −$74.03M
Net Income Q3 2025 · Jun 30, 2025 −$25.34M
Net Income Q3 2025 · Mar 31, 2025 −$28.54M
Net Income Q3 2025 · Sep 30, 2024 −$23.16M
Net Income Q3 2025 · Sep 30, 2024 −$65.84M
Net Income Q3 2025 · Jun 30, 2024 −$19.95M
Net Income Q3 2025 · Mar 31, 2024 −$22.74M
Operating Income Q3 2025 · Sep 30, 2025 −$25.1M
Operating Income Q3 2025 · Sep 30, 2025 −$85.37M
Operating Income Q3 2025 · Sep 30, 2024 −$27.07M
Operating Income Q3 2025 · Sep 30, 2024 −$77.66M